| |
 |
ARTICLES 
|
|
| Residual mass in lymphoma may not be residual disease |
| GP Canellos |
|
JCO Jun 1 1988: 931–933.
[PDF]
|
 |
| Surgical adjuvant treatment of large bowel cancer |
| CG Moertel |
|
JCO Jun 1 1988: 934–936.
[PDF]
|
|
| An argument in support of cost-effectiveness analysis in oncology |
| M Markman |
|
JCO Jun 1 1988: 937–939.
[PDF]
|
|
|
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease |
| |
JA Radford, RA Cowan, M Flanagan, G Dunn, D Crowther, RJ Johnson, and B Eddleston |
| |
JCO Jun 1 1988: 940–946.
[Abstract]
[PDF]
|
|
|
Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study |
| |
FJ Panettiere, PJ Goodman, JJ Costanzi, AB Cruz, Jr, VK Vaitkevicius, JD McCracken, RW Brownlee, L Laufman, RL Stephens, and J Bonnet |
| |
JCO Jun 1 1988: 947–954.
[Abstract]
[PDF]
|
|
|
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck |
| |
J Paredes, WK Hong, TB Felder, IW Dimery, AJ Choksi, RA Newman, AM Castellanos, KT Robbins, K McCarthy, and N Atkinson |
| |
JCO Jun 1 1988: 955–962.
[Abstract]
[PDF]
|
|
|
Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial |
| |
GP Browman, MN Levine, MD Goodyear, R Russell, SD Archibald, BS Jackson, JE Young, V Basrur, and C Johanson |
| |
JCO Jun 1 1988: 963–968.
[Abstract]
[PDF]
|
|
|
Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers |
| |
JE Mortimer, ME Taylor, S Schulman, C Cummings, E Weymuller, Jr, and G Laramore |
| |
JCO Jun 1 1988: 969–975.
[Abstract]
[PDF]
|
|
|
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin |
| |
|
| |
JCO Jun 1 1988: 976–982.
[Abstract]
[PDF]
|
|
|
The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma |
| |
MS Piver, SB Lele, DL Marchetti, TR Baker, Y Tsukada, and LJ Emrich |
| |
JCO Jun 1 1988: 983–989.
[Abstract]
[PDF]
|
|
|
Juvenile granulosa cell tumor of the ovary in children: a clinical study of 15 cases |
| |
G Vassal, F Flamant, JM Caillaud, F Demeocq, C Nihoul-Fekete, and J Lemerle |
| |
JCO Jun 1 1988: 990–995.
[Abstract]
[PDF]
|
|
|
Eight drugs in one day chemotherapy in children with brain tumors: a critical toxicity appraisal |
| |
JR Geyer, TW Pendergrass, JM Milstein, and WA Bleyer |
| |
JCO Jun 1 1988: 996–1000.
[Abstract]
[PDF]
|
|
|
Astrocytoma in children: 14 years' experience at Stanford University Medical Center |
| |
SY Woo, SS Donaldson, and RS Cox |
| |
JCO Jun 1 1988: 1001–1007.
[Abstract]
[PDF]
|
|
|
Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome |
| |
CH Pui, DK Kalwinsky, MJ Schell, CA Mason, J Mirro, Jr, and GV Dahl |
| |
JCO Jun 1 1988: 1008–1013.
[Abstract]
[PDF]
|
|
|
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969 [published erratum appears in J Clin Oncol 1988 Sep;6(9):1522] |
| |
J Gaynor, D Chapman, C Little, S McKenzie, W Miller, M Andreeff, Z Arlin, E Berman, S Kempin, and T Gee |
| |
JCO Jun 1 1988: 1014–1030.
[Abstract]
[PDF]
|
|
|
A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors |
| |
RF Ozols, DC Ihde, WM Linehan, J Jacob, Y Ostchega, and RC Young |
| |
JCO Jun 1 1988: 1031–1040.
[Abstract]
[PDF]
|
|
|
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies |
| |
TE Witzig, NJ Gonchoroff, JA Katzmann, TM Therneau, RA Kyle, and PR Greipp |
| |
JCO Jun 1 1988: 1041–1046.
[Abstract]
[PDF]
|
|
|
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease |
| |
R Farah, J Ultmann, M Griem, H Golomb, U Kalokhe, R Desser, R Blough, and R Weichselbaum |
| |
JCO Jun 1 1988: 1047–1052.
[Abstract]
[PDF]
|
|
|
A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers |
| |
B Ardalan, G Singh, and H Silberman |
| |
JCO Jun 1 1988: 1053–1058.
[Abstract]
[PDF]
|
|
|
Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma |
| |
MN Saleh, DM Miller, L Peterson, CD Russell, MW Unger, MM Urist, RH Wheeler, and AF LoBuglio |
| |
JCO Jun 1 1988: 1059–1065.
[Abstract]
[PDF]
|
|
| Prognostic factors for colon cancer |
| SS Ellenberg, RJ Mayer, and HE Lessner |
|
JCO Jun 1 1988: 1066–1067.
[PDF]
|
|
